Showing results (511-520 of 536) with videos related to

Sort By:
Pageof 54
Plos One|November 3, 2012
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapyAdrian Schwarzer, Benita Wolf, Jan L Fisher, et al.
Genetics|March 10, 2022
FlyBase: a guided tour of highlighted featuresL Sian Gramates, Julie Agapite, Helen Attrill, et al.
JAMA|July 14, 2004
Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trialRalph J DiClemente, Gina M Wingood, Kathy F Harrington, et al.
Fertility and Sterility|December 4, 2012
Identification of a novel gene set in human cumulus cells predictive of an oocyte's pregnancy potentialAmy E Iager, Arif M Kocabas, Hasan H Otu, et al.
Annals of Surgical Oncology|October 8, 2011
Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancerJamie L Wagner, Regina Fearmonti, Kelly K Hunt, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammationSeth M Daly, Bradley O Elmore, Jeffrey S Kavanaugh, et al.
BMJ Open|December 12, 2018
Creation of an Enhanced Recovery After Surgery (ERAS) Guideline for neonatal intestinal surgery patients: a knowledge synthesis and consensus generation approach and protocol studyAshleigh C N Gibb, Megan A Crosby, Caraline McDiarmid, et al.
The Journal of Infectious Diseases|June 15, 2016
Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014Elissa Meites, Pamina M Gorbach, Beau Gratzer, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanomaJeffrey A Sosman, Carole Carrillo, Walter J Urba, et al.
Pageof 54